Zydus Pharmaceuticals Recalls Icosapent Ethyl Capsules Over Subpotency
Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.